Introduction
============

Obstructive sleep apnea-hypopnea syndrome (OSAHS) is the clinical syndrome characterized by relapses of apnea and/or hypopnea, hypercapnia, and sleep interruption caused by a variety of factors that lead to pathophysiologic changes in the body ([@b1-etm-0-0-4851]). OSAHS is a very common otorhinolaryngological disease in children that can cause a series of complicated pathophysiologic processes in the body, leading to different degrees of recurrent airway dysfunction ([@b2-etm-0-0-4851]). The clinical significance of OSAHS is not simply limited to influencing the normal sleep of pediatric patients. At present, studies have shown that OSAHS is closely related to many serious diseases, such as cardiovascular, nerve and metabolic disease ([@b3-etm-0-0-4851],[@b4-etm-0-0-4851]). According to Feng *et al*, OSAHS can cause fluctuations of thyroid hormone levels in children, the inability to concentrate, and lower the quality of life ([@b5-etm-0-0-4851]). In addition, Sforza *et al*, reported that the mean body mass index (BMI) of most children with OSAHS was significantly higher than that of normal children ([@b6-etm-0-0-4851]). Furthermore, acute changes of oxyhemoglobin saturation in children with OSAHS during the process of nocturnal sleep can cause hypoxia stress ([@b7-etm-0-0-4851]), resulting in the release of inflammatory cells and inflammatory cytokines, such as lymphocytes, neutrophils, TREM-1, and pentraxin-3. These inflammatory cells and cytokines can cause endothelial injury and further aggravate obesity ([@b8-etm-0-0-4851]) and hypertension ([@b9-etm-0-0-4851]). Obesity is the most dangerous pathogenic factor causing OSAHS ([@b10-etm-0-0-4851]). The brain is the organ with the largest oxygen consumption in the body during sleep. Therefore, Roubille *et al* ([@b11-etm-0-0-4851]) hypothesized that hypoxia during sleep can lead to local cerebral blood flow obstruction. After the diagnosis of OSAHS, positive and effective treatment measures should be taken to prevent a series of pathological reactions caused by OSAHS. The therapeutic regimen of OSAHS should be determined primarily according to the pathogenesis and clinical manifestations of pediatric patients.

In China, there is a lack of understanding of OSAHS in children. Therefore, according to recent guidelines on pediatric OSAHS from the American Academy of Pediatrics ([@b1-etm-0-0-4851]), polysomnogram (PSG) monitoring should be performed for patients with obvious signs and symptoms, to monitor the nocturnal sleep disorder process and help provide corresponding treatment. However, it is insufficient for the therapeutic regimen to depend only on the results of PSG combined with clinical manifestations. The systematic evaluation of risk factors of OSAHS in children is necessary to achieve individualized treatment ([@b12-etm-0-0-4851]).

Increasing evidence has indicated that OSAHS can be treated with drugs, such as steroids or montelukast. However, this is only limited to pediatric patients with apnea-hypopnea index (AHI) grading between 5 and 20. For patients with AHI grading \>20, adenoidectomy can serve as a form of clinical treatment for effectively controlling OSAHS. Some pediatric patients with OSAHS are accompanied by adenoidal hypertrophy. These patients are usually treated with adenoidectomy or transoral endoscopic adenoidectomy ([@b13-etm-0-0-4851]). In the present study, transoral endoscopic adenoidectomy was performed and changes of preoperative and postoperative peripheral blood T lymphocyte subsets in children with OSAHS were analyzed, to investigate the influence of OSAHS on the immune system.

Patients and methods
====================

### Patients

After obtaining approval from the Xuzhou Children\'s Hospital Ethics Committee and informed consent from the family of patients, 98 pediatric patients with OSAHS diagnosed via auxiliary diagnostic methods, such as with an imaging and sleep breathing detector, were screened, including 49 males and 49 females, with an average age of 4.61±1.57 years. The disease duration was 1.5--4.5 years, with an average of 2.32±1.27 years. After admission, the patients received perfected clinical routine blood examination, blood biochemistry examination, 24 h sleep breathing detection, and 24 h ambulatory blood pressure monitoring. The general clinical conditions of pediatric patients are shown in [Table I](#tI-etm-0-0-4851){ref-type="table"}.

### Inclusion and exclusion criteria

Inclusion criteria for the study were: i) Patients who were diagnosed with adenoidal hypertrophy associated with OSAHS via clinical examination, medical history, and clinical manifestations; ii) patients who cried loudly during the process of examination and treatment, and whose families agreed to the use of sedative drugs; iii) patients whose adenoid was the only cause of OSAHS; and iv) patients without history of palatorrhaphy.

Exclusion criteria for the study were: i) Patients with lung diseases such as bronchial asthma, lung tissue cystic fibrosis, and active tuberculosis; ii) patients with malignant tumors in the respiratory system; iii) patients who underwent surgery, suffered trauma in a traffic accident, or had infections in other parts of the body; iv) patients with central sleep apnea syndrome, thyroid hypofunction, acromegaly, narcolepsy, laryngospasm, vocal cord paralysis, epilepsy, or neuromuscular disease; v) patients with cognitive impairment or mental disease; vi) patients whose blood sample failed to be obtained; vii) patients with dysfunction of bleeding or blood coagulation; viii) patients with suspected middle ear effusion according to acoustic immitance test; ix) patients with submucous cleft palate; x) patients lost to follow-up; and xi) patients or their families who failed to cooperate in examination and treatment.

### Examination methods

Routine blood and blood biochemical examination: Sterile whole venous blood (4--6 ml) was drawn and placed in BD vacuum sterile sodium citrate anticoagulation tubes. Monoclonal antibody measurements (Bio-Rad Laboratories, Inc., Hercules, CA, USA) were used for the quantitative detection and analysis of T lymphocyte subsets; a fully-automated biochemical detector (Abbott Laboratories, Abbott Park, IL, USA) was used for blood biochemical examination.

Diagnostic criteria of nasopharyngeal true lateral X-ray: The vertical distance from the most projecting point of the adenoid to the surface of the skull base bone was taken as the thickness of the adenoid. The distance from the rear end of the hard palate to the intersection of the alar plate and skull base was taken as the width of the nasopharyngeal airway. The ratio between the thickness of the adenoid and the width of the nasopharyngeal airway was taken as the judgment standard:

i\) Diagnostic range of the ratio between the thickness of the adenoid and the width of the nasopharyngeal airway (A/N value): Normal, A/N 0.5--0.6; severe hypertrophy, A/N 0.61--0.70; pathologic hypertrophy, A/N \>0.71.

ii\) Anteroposterior diameter (D-value) of effective nasopharyngeal cavity airway: Normal, \>4 mm; adenoidal hypertrophy, \<3 mm.

### PSG

A PSG monitor (SOMNOmedics GmbH, Randersacker, Germany) was used to monitor indicators including the EEG and 24 h ambulatory blood pressure, snoring frequency and phase angle, respiratory gas plethysmography, carbon dioxide, oxyhemoglobin saturation, Cheyne-Stokes respiration, odontoprisis, body temperature, and EEG spike wave. The highest sample frequency was 2,048 Hz.

i\) AHI grading of OSAHS: Mild, AHI 5--20; moderate, AHI 21--40; severe, AHI \>40.

ii\) Hypoxemia grading of OSAHS: Mild, SaO~2min~ \>85%; moderate, SaO~2min~ 65--84%; severe, SaO~2min~ \<65.

Note: OSAHS grading was based on AHI, and the condition of hypoxemia was indicated. For example, for AHI=25 and minimum SaO~2~ (%) = 88, it was reported as 'moderate OSHAS complicated with mild hypoxemia'.

### Transoral endoscopic adenoidectomy ([@b13-etm-0-0-4851])

i\) Preoperative evaluation: a) Before surgery, the general condition of patients was examined, and other potential diseases were ruled out; b) comprehensive physical examination and medical history was collected; and c) nasopharyngeal true lateral X-ray was performed.

ii\) Construction of the oral channel: During tracheal intubation under general anesthesia, a Boyle-Davis mouth opener was used to keep the mouth open. The bilateral rubber hose was inserted from the nose end to the mouth end, and both ends were clamped with an artery clamp. The bilateral rubber hose was retracted, and the oral channel was constructed.

iii\) Connection: A 70°, 4-mm Hopkins nasal endoscope was used through the constructed oral channel, and the quality of the adenoid was determined.

iv\) Adenoidectomy: The cameras in the endoscope were installed, and the endoscope was connected to the monitor. After the imaging was clear, the special endoscope adenoid curette was used to strike off most of the adenoid in the diseased region. St. Claire-Thomson forceps were used to remove residual adenoid tissues. Excessive intraoperative bleeding was usually rare, especially after nasopharyngeal lymphoid tissue was removed completely.

v\) End of surgery: When surgery was close to completion, sterile gauze was inserted into the nasopharyngeal region of patients, and pressed for a few minutes until the tonsils were fully removed (patients complicated with tonsil hypertrophy could receive preventative tonsil removal). See the operative process.

### Postoperative follow-up

We collected data on the clinical blood and biochemical indexes of patients after surgery by means of telephone, SMS, and WeChat follow-ups, and performed statistical analyses. Patients lost to follow-up (migrated, went abroad and downtime) were ruled out. All the patients included in this study received postoperative follow-up.

### Statistical analysis

SPSS 19.0 (Chicago, IL, USA) statistical analysis software was used to collect, process, and analyze data. Continuous variables are presented as mean ± SD (standard deviation). Continuous variables with skewed distribution are presented as median and interquartile range. Classified variables are presented as the absolute percentage. The Student\'s t-test was used for continuous variables, and the χ^2^ test was used for the comparison of classified variables. P\<0.05 suggested that the difference was statistically significant. Pearson\'s correlation analysis was used for the statistics of the correlation between various risk factor indexes, and the correlation coefficient r was calculated.

Results
=======

### Nasopharyngeal CT index evaluation for pediatric patients with OSAHS before and after adenoidectomy (mean ± SD)

Nasopharyngeal X-ray was used to review patients after transoral endoscopic adenoidectomy to determine the results of surgery. The results showed that the postoperative A/N ratio (0.23±0.15) in 98 patients was significantly decreased (T=21.27, P=0.03). The D-value (4.4±1.6 mm) was significantly decreased (T=18.92, P=0.03). The anatomically obstructive factor was removed, indicating that the surgery was successful ([Table II](#tII-etm-0-0-4851){ref-type="table"}).

### Statistics and analysis of clinical blood test results for pediatric patients with OSAHS (mean ± SD)

CD3^+^ T-cell count and percentage, CD4^+^ T-cell count and percentage, and CD8^+^ T-cell count and percentage in pediatric patients were collected and recorded, followed by statistical analysis. We found that the postoperative CD4^+^ T-cell count and percentage in patients were increased significantly (P=0.01), and the CD4^+^/CD8^+^ ratio was increased significantly (P=0.01). The changes of CD3^+^ T lymphocyte count and CD8^+^ T cells were not significantly different (P\>0.05) ([Table III](#tIII-etm-0-0-4851){ref-type="table"}).

### Evaluation of sleep quality of pediatric patients with OSAHS before and after adenoidectomy (mean ± SD)

Through postoperative follow-up observation and the comparison of the number of awakenings and average continuous sleep time during the sleep of patients with OSAHS before and after adenoidectomy, the number of awakenings during sleep after surgery was found to be decreased significantly (T=19.33, P=0.03); the average continuous sleep time was 612.43±12.63 min, which was significantly increased compared with before surgery (T=18.93, P=0.03); the average oxyhemoglobin saturation during sleep was 95.3±2.7%, which was significantly higher than that before surgery (T=21.28, P=0.03) ([Table IV](#tIV-etm-0-0-4851){ref-type="table"}).

### Evaluation of MAP and blood biochemical indexes in pediatric patients with OSAHS before and after adenoidectomy (mean ± SD)

Through the measurement of mean arterial pressure (MAP), BMI, and various blood biochemical indexes in pediatric patients before and after transoral endoscopic adenoidectomy, it was found that MAP was 75.0±14.2 mmHg in the third week after surgery, which was significantly decreased compared with that before surgery (F=2.97, P=0.026). From the sixth week after surgery, low-density lipoprotein cholesterol (LDL-C) was 2.01±0.16 mmol/l, which was significantly decreased compared with that before surgery. Triglyceride (TG) level was 1.02±0.88 mmol/l in the sixth week after surgery, which was significantly decreased compared with that before surgery (F=3.35, P=0.035). However, there was no significant difference in fasting blood glucose (F=0.26, P=0.462) ([Table V](#tV-etm-0-0-4851){ref-type="table"}).

### Correlation analysis of CD4^+^/CD8^+^ T lymphocyte ratio and MAP

It was found through previous studies that effective adenoidectomy significantly improved the peripheral blood CD4^+^/CD8^+^ T-cell ratio in pediatric patients with OSAHS. However, we found that the potential influential factors including the 24 h MAP, 24 h sleep time, 24 h average oxyhemoglobin saturation, BMI, blood TG, blood LDL-C, and course of OSAHS, may be related to the CD4^+^/CD8^+^ T-cell ratio via review of the literature and clinical experience. The CD4^+^/CD8^+^ T-cell ratio was taken as the independent variable to perform the correlation analysis with a series of indexes mentioned above. Pearson\'s correlation analysis showed that the CD4^+^/CD8^+^ T lymphocyte ratio had a significantly negative correlation with 24 h MAP (r=−1.33, P=0.001), a positive correlation with average oxyhemoglobin saturation during sleep (r=1.04, P=0.010), and no significant correlation with 24-h sleep time or 24 h average oxyhemoglobin saturation (P\>0.05) ([Tables VI](#tVI-etm-0-0-4851){ref-type="table"} and [VII](#tVII-etm-0-0-4851){ref-type="table"}).

Discussion
==========

With recent development of internal passing technology, transoral endoscopic adenoidectomy has gradually replaced adenoidectomy and has become the primary surgical method for the treatment of adenoidal hypertrophy and apnea syndrome caused by adenoidal hypertrophy in children. Its main advantages are that it is minimally invasive and the postoperative recovery is fast. The nasopharyngeal space of children is limited, but blood flow is widely distributed to that region. Therefore, blind excision usually causes bleeding and incomplete resection of the adenoid may cause it to develop again ([@b13-etm-0-0-4851]). In terms of surgical evaluation, the A/N ratio and D-value are widely used to analyze the nasopharyngeal anatomical structure in OSAHS. In our study, 98 pediatric patients diagnosed with adenoidal hypertrophy were randomly enrolled after being screened according to the inclusion and exclusion criteria, and underwent transoral endoscopic adenoidectomy. After surgery, the A/N ratio was 0.23±0.15, which was significantly decreased (T=21.27, P=0.03) and the D-value was 4.4±1.6 mm, which was significantly decreased (T=18.93, P=0.03). This shows that the potential anatomical obstructive factors in the nasopharynx of children with OSAHS were removed after adenoidectomy, which is important for the treatment of OSAHS.

In the past, some scholars hypothesized that the largest effect of OSAHS on pediatric patients is a series of stress reactions caused by hypoxia. The currently recognized obstructive sleep apnea (OSA) can promote and activate the systemic inflammatory response, including a variety of pro-inflammatory cytokines, such as interleukin (IL)-6, IFN-γ, and TNF-α ([@b14-etm-0-0-4851]--[@b16-etm-0-0-4851]).

It was found that the anti-inflammatory cytokine, IL-10, is significantly decreased in children with OSA, which indicates that there are potential inflammatory responses in the body of patients with OSA, and that these inflammatory cytokines have certain effects on regulating blood lipids, blood glucose, and blood pressure ([@b17-etm-0-0-4851]). The signaling cascades initiated by hypoxia are controlled by genes. At present, the promoter region of the *Foxp3* gene has been shown to play an important role in regulatory T (Treg) cell transcription and differentiation, and is highly dependent on methylation in children with OSA. Treg cells are capable of differentiating into CD4^+^ T~h~ cells, which play an important role in certain autoimmune diseases ([@b18-etm-0-0-4851]).

After removing the obstructive factors, we evaluated the peripheral blood T lymphocyte subsets and a variety of blood biochemical indexes in pediatric patients, and found that the CD4^+^ T cell count and percentage were increased significantly after surgery (P=0.01). Additionally, the CD4^+^/CD8^+^ ratio was increased significantly (P=0.01). Our results were consistent with those of previous studies ([@b16-etm-0-0-4851],[@b18-etm-0-0-4851]).

It is reported in the literature that there is a certain correlation between OSAHS and obesity. The relationship between obesity and OSA was initially identified in epidemiological studies ([@b19-etm-0-0-4851]). In many developed countries, there appears to be a relationship between obesity and OSA in children. With increasing numbers of children being diagnosed with OSA, more non-obese children with OSA have been accompanied with adenoidal hypertrophy. However, a study on OSA in obese and non-obese children showed that the Mallampati score of obese children was significantly higher, greatly increasing their risk of OSA ([@b20-etm-0-0-4851]). However, such risk is not caused by lymph node hyperplasia. Instead, it is because substantial space is occupied and breathing is therefore directly inhibited. The oxidative stress caused by hypoxia leads to disorder in the metabolism of blood sugar, blood fat and protein. Therefore, blood sugar and blood fat are increased, and large amounts of lactose produced by anaerobic glycolysis make it easier for pediatric patients to suffer from metabolic acidosis ([@b20-etm-0-0-4851]). Combined with the inhibition in transcription and differentiation of Treg cells, this leads to a significant decrease of CD4^+^ T~h~ cells in the body. As a result, the patient\'s resistance to outside pathogens is weakened (CD4^+^ T~h~ cells are mainly involved in specific cellular immunity), and some autoimmune diseases may occur, such as type 1 diabetes ([@b21-etm-0-0-4851]).

In addition, it is common in children with OSAHS that long-term sleep disorder causes sympathetic nerve dysfunction, reflex blood pressure increase, and other internal changes ([@b22-etm-0-0-4851]). In our study, the blood lipid levels of most patients were close to the normal upper limit, and even exceeded it. In addition, a potential decline in glucose tolerance occurred in some patients. However, MAP was 75.0±14.2 mmHg in the third week after adenoidectomy, which was significantly decreased compared with that before surgery (F=2.97, P=0.026). From the sixth week after surgery, LDL-C was 2.01±0.17 mmol/l, which was significantly decreased compared with that before surgery. TG level was 1.02±0.85 mmol/l in the sixth week, which was significantly decreased compared with that before surgery (F=3.35, P=0.035). We believe that the factor causing anatomical obstruction in pediatric patients was fundamentally removed. Therefore, the anoxic condition of children was improved and the metabolic activity in the body gradually returned to normal.

We found significant changes in a variety of indexes before and after surgery. Furthermore, we hope to conduct correlation analyses to study the internal relation behind these indexes. We conducted the Pearson\'s correlation analysis with CD4^+^/CD8^+^ T lymphocyte ratio as the independent variable and other indexes as dependent variables, and found that the CD4^+^/CD8^+^ T lymphocyte ratio had a negative correlation with MAP (r=−1.33, P=0.001), and a positive correlation with average oxyhemoglobin saturation during sleep (r=1.04, P=0.010).

Present studies suggest that there is no significant direct correlation between blood pressure and T-cell subset differentiation ([@b23-etm-0-0-4851]). We suspect through the above analysis and literature review that this may be because the change of oxyhemoglobin saturation in pediatric patients changes the CD4^+^/CD8^+^ T lymphocyte ratio. Additionally, the oxidative stress caused by hypoxia and increases of H^+^ and CO~2~ concentration increase the tension of sympathetic nerves through the effect of the carotid sinus and aortic arch chemoreceptor, thus increasing blood pressure ([@b23-etm-0-0-4851]). Therefore, we believe that MAP and peripheral blood T lymphocyte subsets can be used as important indexes for evaluating disease progression in children with OSAHS. This further supports the idea that regardless of treatment method, the key to treatment of OSAHS is to eliminate the primary cause of obstruction in patients, to correct the anoxic condition.

In conclusion, we believe transoral endoscopic adenoidectomy has a very good therapeutic effect on removing upper respiratory tract obstruction in pediatric patients with OSAHS. Hypoxia and MAP are the primary factors influencing the peripheral blood CD4^+^/CD8^+^ T lymphocyte ratio, and can be used as indexes for evaluating disease progression in children with OSAHS.

###### 

General clinical conditions of 98 pediatric patients with OSAHS (mean ± SD).

  Age (years)   Duration of OSAHS (months)   Fasting blood glucose (mmol/l)       MAP (mmHg)                TG (mmol/l)   LDL-C (mmol/l)                                  BMI (kg/m^2^)
  ------------- ---------------------------- ------------------------------------ ------------------------- ------------- ----------------------------------------------- ---------------
  4.78±1.64     2.38±1.67                    5.47±1.82                            108.2±12.1                1.59±0.44     3.10±1.49                                       21.43±3.48
  A/N           D-value (mm)                 Duration of continuous sleep (min)   Time of sleep awakening   AHI           Average oxyhemoglobin saturation during sleep   
                                                                                                                                                                          
  0.79±0.22     2.12±0.74                    384.33±24.78                         18.73±7.92                48.33±12.78   86.41±7.28                                      

OSAHS, obstructive sleep apnea-hypopnea syndrome; MAP, mean arterial pressure; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; BMI, body mass index; AHI, apnea-hypopnea index.

###### 

Nasopharyngeal X-ray index evaluation for children with OSAHS before and after adenoidectomy (mean ± SD).

  Index          Case no. (n)   Before surgery   After surgery   T-value   P-value
  -------------- -------------- ---------------- --------------- --------- ---------
  A/N            98             0.79±0.22        0.23±0.15       21.27     0.03
  D-value (mm)   98             2.14±0.72        4.42±1.68       18.93     0.03

OSAHS, obstructive sleep apnea-hypopnea syndrome.

###### 

Classified statistical results of T lymphocyte subsets at each follow-up for pediatric patients with OSAHS before and after transoral endoscopic adenoidectomy.

  Item                           Before surgery   3 weeks after surgery   6 weeks after surgery   12 weeks after surgery   F-value   P-value
  ------------------------------ ---------------- ----------------------- ----------------------- ------------------------ --------- ---------
  CD3^+^ T cell count (/l)       1237.4±128.48    957.43±74.29            967.68±58.52            913.38±124.62            0.38      0.66
  CD3^+^ T cell percentage (%)   0.58±0.24        0.52±0.17               0.68±0.12               0.62±0.28                0.43      0.66
  CD4^+^ T cell count (/l)       461.74±85.58     504.63±69.53            709.43±92.53            712.29±78.55             0.52      0.59
  CD4^+^ T cell percentage (%)   39.21±12.37      52.68±18.74             59.95±12.39             63.33±9.43               6.39      0.01
  CD8^+^ T cell count (/l)       327.32±54.55     495.79±75.82            593.24±55.46            601.93±35.52             0.84      0.51
  CD8^+^ T cell percentage (%)   439.43±72.44     501.74±101.76           479.42±117.41           463.74±92.41             0.32      0.74
  CD4^+^/CD8^+^                  0.98±1.45        1.48±0.19               1.88±1.16               2.24±0.36                2.56      0.01

OSAHS, obstructive sleep apnea-hypopnea syndrome.

###### 

Sleep quality index evaluation at follow-up for pediatric patients with OSAHS (mean ± SD).

  Index                             Case no. (n)   Before surgery   After surgery   T-value   P-value
  --------------------------------- -------------- ---------------- --------------- --------- ---------
  No. of awakenings during sleep    98             18.74±7.92       2.32±1.51       19.27     0.03
  Continuous sleep time (min)       98             384.33±24.73     612.43±12.36    18.93     0.03
  Average SPO~2~ during sleep (%)   98             86.44±7.21       95.33±2.79      21.28     0.03
  AHI during sleep                  98             48.31±12.78      9.61±10.54      32.73     0.02

OSAHS, obstructive sleep apnea-hypopnea syndrome; AHI, apnea-hypopnea index.

###### 

Evaluation of mean arterial pressure and blood biochemical indexes in pediatric patients with OSAHS before and after adenoidectomy (mean ± SD).

  Item                     BMI (kg/m^2^)   MAP (mmHg)   FBG (mmol/l)   LDL-C (mmol/l)   TG (mmol/l)
  ------------------------ --------------- ------------ -------------- ---------------- -------------
  Before operation         21.4±3.4        107.2±13.1   5.37±1.62      3.09±1.48        1.58±0.24
  3 weeks after surgery    21.1±1.2        75.0±14.2    5.68±0.12      3.11±0.24        1.62±0.28
  6 weeks after surgery    18.7±0.5        72.6±19.5    4.73±0.25      2.01±0.17        1.02±0.85
  12 weeks after surgery   17.2±2.3        73.6±12.7    4.89±1.03      1.92±0.33        0.93±0.94
  F-value                  2.37            2.97         0.26           2.37             3.35
  P-value                  0.013           0.026        0.462          0.004            0.035

OSAHS, obstructive sleep apnea-hypopnea syndrome; BMI, body mass index; MAP, mean arterial pressure; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride.

###### 

Correlation analysis of CD4^+^/CD8^+^ ratio and various clinical test indexes.

  Index           Gender    Age       Course of OSAHS (months)      Fasting blood glucose (mmol/l)   MAP (mmHg)    TG (mmol/l)                                     LDL-C (mmol/l)   BMI (kg/m^2^)
  --------------- --------- --------- ----------------------------- -------------------------------- ------------- ----------------------------------------------- ---------------- ---------------
  CD4^+^/CD8^+^                                                                                                                                                                     
  r               0.02      0.35      0.17                          0.08                             −1.33         0.23                                            0.16             0.14
  P-value           0.331     0.722     0.040                         0.181                            0.001         0.299                                           0.022            0.017
  Index           A/N       AHI       Continuous sleep time (min)   No. of awakening during sleep    AHI grading   Average oxyhemoglobin saturation during sleep                    
                                                                                                                                                                                    
  CD4^+^/CD8^+^                                                                                                                                                                     
  r               0.17      0.45      0.16                          0.49                             0.98          1.04                                                             
  P-value           0.272     0.493     0.731                         0.606                            0.371         0.010                                                          

OSAHS, obstructive sleep apnea-hypopnea syndrome; MAP, mean arterial pressure; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; BMI, body mass index.

###### 

Linear-regression analysis of influential factor of CD4^+^/CD8^+^ T lymphocyte ratio in pediatric patients with OSAHS.

                                                                                         95% CI   
  ----------------------------------------------- ------- ------ ------- -------- ------ -------- ------
  Course of OSAHS                                 0.531   0.14   0.764   1.412    0.39   0.26     0.81
  LDL-C                                           0.768   0.08   0.673   1.673    0.34   0.88     0.61
  Average oxyhemoglobin saturation during sleep   0.581   0.10   0.642   18.652   0.03   0.78     0.39
  MAP                                             0.435   0.04   0.782   8.37     0.03   0.51     0.36
  BMI                                             0.768   0.08   0.871   0.981    0.50   0.61     0.92

OSAHS, obstructive sleep apnea-hypopnea syndrome; LDL-C, low-density lipoprotein cholesterol; MAP, mean arterial pressure; BMI, body mass index.
